Fintel reports that on November 3, 2025, HC Wainwright & Co. maintained coverage of Plus Therapeutics (NasdaqCM:PSTV) with a Buy recommendation. Analyst Price Forecast Suggests 1,402.76% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results